Marek Krzanowski

Marek Krzanowski

Auto-generated profile, based on publicly available information

Marek Krzanowski

ANGIO-MEDICUS Angiology Clinic, Kraków, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
TZThomas Zeller
Thomas Zeller
RLRalf Langhoff
Ralf Langhoff
KRKrishna J. Rocha-Singh
Krishna J. Rocha-Singh
MJMichael R. Jaff
Michael R. Jaff
EBErwin Blessing
Erwin Blessing
GTGunnar Tepe
Gunnar Tepe
Background—: Studies assessing drug-coated balloons (DCB) for the treatment of femoropopliteal artery disease are encouraging. However, challenging lesions, such as severely calcified, remain difficult to treat with DCB alone. Vessel preparation with directional atherectomy (DA) potentially improves outcomes of DCB. Methods and Results—: DEFINITIVE AR study (Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency—A Pilot Study of Anti-Restenosis Treatment) was a multicenter randomized trial designed to estimate the effect of DA before DCB to facilitate the development of future end point-driven randomized studies. One hundred two patients with claudication or rest pain were randomly assigned 1:1 to DA+DCB (n=48) or DCB alone (n=54), and 19 additional patients with severely calcified lesions were treated with DA+DCB. Mean lesion length was 11.2±4.0 cm for DA+DCB and 9.7±4.1 cm for DCB ( P =0.05). Predilation rate was 16.7% for DA+DCB versus 74.1% for DCB; postdilation rate was 6.3% for DA+DCB versus 33.3% for DCB. Technical success was superior for DA+DCB (89.6% versus 64.2%; P =0.004). Overall bail-out stenting rate was 3.7%, and rate of flow-limiting dissections was 19% for DCB and 2% for DA+DCB ( P =0.01). One-year primary outcome of angiographic percent diameter stenosis was 33.6±17.7% for DA+DCB versus 36.4±17.6% for DCB ( P =0.48), and clinically driven target lesion revascularization was 7.3% for DA+DCB and 8.0% for DCB ( P =0.90). Duplex ultrasound patency was 84.6% for DA+DCB, 81.3% for DCB ( P =0.78), and 68.8% for calcified lesions. Freedom from major adverse events at 1 year was 89.3% for DA+DCB and 90.0% for DCB ( P =0.86). Conclusions—: DA+DCB treatment was effective and safe, but the study was not powered to show significant differences between the 2 methods of revascularization in 1-year follow-up. An adequately powered randomized trial is warranted. Clinical Trial Registration—: http://www.clinicaltrials.gov . Unique Identifier: NCT01366482.

1 September 2019 in International Angiology
Verified
Journal Article
Closed access
PAPier Luigi Antignani
Pier Luigi Antignani
ZLZaza Lazarashvili
Zaza Lazarashvili
JMJavier L. Monedero
Javier L. Monedero
SESantiago Z. Ezpeleta
Santiago Z. Ezpeleta
Mark Steven WhiteleyMark Steven Whiteley
Mark Steven Whiteley
MWMarald Wikkeling
Marald Wikkeling

17 November 2003 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
MKMarek Krzanowski
Marek Krzanowski
WBWojciech Bodzoń
Wojciech Bodzoń
PDPawel Petkow Dimitrow
Pawel Petkow Dimitrow
Improvements in ultrasound technology has enabled direct, transthoracic visualization of long portions of coronary arteries : the left anterior descending (LAD), circumflex (Cx) and right coronary artery (RCA). Transthoracic measurements of coronary flow velocity were proved to be highly reproducible and correlated with invasive measurements. While clinical applications of transthoracic echocardiography (TTE) of principal coronary arteries are still very limited they will likely grow. The echocardiographers may therefore be interested to know the ultrasonic views, technique of examination and be aware where to look for coronary arteries and how to optimize the images. A step-by-step approach to direct, transthoracic visualization of the LAD, Cx and RCA is presented. The technique of examination is discussed, correlations with basic coronary angiography views and heart anatomy are shown and extensively illustrated with photographs and movie-pictures. Hints concerning optimization of ultrasound images are presented and artifacts of imaging are discussed. Direct, transthoracic examination of the LAD, Cx and RCA in adults is possible and may become a useful adjunct to other methods of coronary artery examination but studies are needed to establish its role.

1 January 2003 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
ENE. Nizankowska-Mogilnicka
E. Nizankowska-Mogilnicka
LAL. Adamek
L. Adamek
PGP. Grzanka
P. Grzanka
TDTeresa Barbara Domagała
Teresa Barbara Domagała
MSMarek Sanak
Marek Sanak
ASA. Szczeklik
A. Szczeklik
Frequently an inherited predisposition to thrombosis remains clinically silent until an additional environmental factor intervenes. The present study aimed to assess distribution of inherited risk factors of venous thrombosis in patients with venous thromboembolism (VTE).The prevalences of factor V Leiden (FV Leiden), prothrombin factor II G20210A (FII G20210A), C677T and A1298C of methylenetetrahydrofolate reductase (MTHFR) mutations were studied in 149 VTE patients and 100 controls.The following key risks were established: previous deep venous thrombosis or pulmonary embolism (23.5%), bed rest (34.2%), immobilisation of lower limb (10.1%), hospitalisation (30.9%) and obesity (28.9%). In 29 (19%) patients and in three (3%) controls FV Leiden was found. A significant association between VTE and FV Leiden was established. There were six (4%) carriers of the FII G20210A among VTE patients and one in the controls. No associations between VTE and MTHFR polymorphisms (C677T, A1298C) were found. In three of 149 patients both FV Leiden and FII G20210A polymorphisms were observed. The mean protein C activity was slightly, though nonsignificantly, smaller in VTE patients.In conclusion, there was a positive association between venous thromboembolism and factor V Leiden. Only a weak trend favouring a relationship between prothrombin factor II G20210A and venous thrombolism was present. No associations between common polymorphisms of methylenetetrahydrofolate reductase and venous thromboembolism were found.

1 December 2000 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
MKMarek Krzanowski
Marek Krzanowski
WBWojciech Bodzoń
Wojciech Bodzoń
TBTomasz Brzostek
Tomasz Brzostek
RNRafał Niżankowski
Rafał Niżankowski
ASAndrzej Szczeklik
Andrzej Szczeklik

1 November 2019 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
MKMarek Krzanowski
Marek Krzanowski
LPLukasz Partyka
Lukasz Partyka
LDLukasz Drelicharz
Lukasz Drelicharz
MMMalgorzata Mielnik
Malgorzata Mielnik
MFMarzena Frolow
Marzena Frolow
TATomasz Aleksiejew-Kleszczynski
Tomasz Aleksiejew-Kleszczynski